Boston Scientific Q4 and FY25 Earnings Results

Friday, Feb 6, 2026 12:58 am ET1min read
BSX--

Boston Scientific has reported Q4 and full year 2025 results, with Chairman and CEO Mike Mahoney and CFO Jon Monson discussing the results. The company's operational revenue excludes the impact of foreign currency fluctuations, and organic revenue excludes certain acquisitions and divestitures. Guidance excludes the previously announced agreement to acquire Valencia Technologies Corporation and Penumbra. Forward-looking statements regarding the company's financial performance, business plans, and product performance and development were also discussed.

Boston Scientific Q4 and FY25 Earnings Results

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet